vs
Idexx Laboratories（IDXX）与Cloudflare, Inc.（NET）财务数据对比。点击上方公司名可切换其他公司
Idexx Laboratories的季度营收约是Cloudflare, Inc.的1.8倍（$1.1B vs $614.5M），Idexx Laboratories净利率更高（22.8% vs -2.0%，领先24.7%），Cloudflare, Inc.同比增速更快（33.6% vs 14.3%），Idexx Laboratories自由现金流更多（$326.3M vs $105.2M），过去两年Cloudflare, Inc.的营收复合增速更高（27.4% vs 6.4%）
IDEXX Laboratories是1983年成立的美国跨国企业，主营伴侣动物诊疗、畜禽养殖、水质检测、乳制品领域相关产品与服务的研发、生产及分销，总部位于缅因州韦斯特布鲁克，欧洲、中东及非洲地区分部设于荷兰霍夫多普。
Cloudflare是总部位于美国加利福尼亚州旧金山的科技企业，提供内容分发网络（CDN）、云网络安全、DDoS防护等多元互联网服务，同时是ICANN认证的域名注册商。其服务作为网站访客与客户托管服务商之间的反向代理，可有效提升访问性能，抵御恶意流量。
IDXX vs NET — 直观对比
营收规模更大
IDXX
是对方的1.8倍
$614.5M
营收增速更快
NET
高出19.3%
14.3%
净利率更高
IDXX
高出24.7%
-2.0%
自由现金流更多
IDXX
多$221.1M
$105.2M
两年增速更快
NET
近两年复合增速
6.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.1B | $614.5M |
| 净利润 | $248.2M | $-12.1M |
| 毛利率 | 60.3% | 73.6% |
| 营业利润率 | 28.9% | -8.0% |
| 净利率 | 22.8% | -2.0% |
| 营收同比 | 14.3% | 33.6% |
| 净利润同比 | 14.8% | 6.0% |
| 每股收益（稀释后） | $3.09 | $-0.03 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收IDXXNET
| Q4 25 | $1.1B | $614.5M | ||
| Q3 25 | $1.1B | $562.0M | ||
| Q2 25 | $1.1B | $512.3M | ||
| Q1 25 | $998.4M | $479.1M | ||
| Q4 24 | $954.3M | $459.9M | ||
| Q3 24 | $975.5M | $430.1M | ||
| Q2 24 | $1.0B | $401.0M | ||
| Q1 24 | $964.1M | $378.6M |
净利润IDXXNET
| Q4 25 | $248.2M | $-12.1M | ||
| Q3 25 | $274.6M | $-1.3M | ||
| Q2 25 | $294.0M | $-50.4M | ||
| Q1 25 | $242.7M | $-38.5M | ||
| Q4 24 | $216.1M | $-12.8M | ||
| Q3 24 | $232.8M | $-15.3M | ||
| Q2 24 | $203.3M | $-15.1M | ||
| Q1 24 | $235.6M | $-35.5M |
毛利率IDXXNET
| Q4 25 | 60.3% | 73.6% | ||
| Q3 25 | 61.8% | 74.0% | ||
| Q2 25 | 62.6% | 74.9% | ||
| Q1 25 | 62.4% | 75.9% | ||
| Q4 24 | 59.8% | 76.4% | ||
| Q3 24 | 61.1% | 77.7% | ||
| Q2 24 | 61.7% | 77.8% | ||
| Q1 24 | 61.5% | 77.5% |
营业利润率IDXXNET
| Q4 25 | 28.9% | -8.0% | ||
| Q3 25 | 32.1% | -6.7% | ||
| Q2 25 | 33.6% | -13.1% | ||
| Q1 25 | 31.7% | -11.1% | ||
| Q4 24 | 27.4% | -7.5% | ||
| Q3 24 | 31.2% | -7.2% | ||
| Q2 24 | 26.3% | -8.7% | ||
| Q1 24 | 31.0% | -14.4% |
净利率IDXXNET
| Q4 25 | 22.8% | -2.0% | ||
| Q3 25 | 24.8% | -0.2% | ||
| Q2 25 | 26.5% | -9.8% | ||
| Q1 25 | 24.3% | -8.0% | ||
| Q4 24 | 22.7% | -2.8% | ||
| Q3 24 | 23.9% | -3.6% | ||
| Q2 24 | 20.3% | -3.8% | ||
| Q1 24 | 24.4% | -9.4% |
每股收益（稀释后）IDXXNET
| Q4 25 | $3.09 | $-0.03 | ||
| Q3 25 | $3.40 | $0.00 | ||
| Q2 25 | $3.63 | $-0.15 | ||
| Q1 25 | $2.96 | $-0.11 | ||
| Q4 24 | $2.62 | $-0.05 | ||
| Q3 24 | $2.80 | $-0.04 | ||
| Q2 24 | $2.44 | $-0.04 | ||
| Q1 24 | $2.81 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $180.1M | $943.5M |
| 总债务越低越好 | $450.0M | — |
| 股东权益账面价值 | $1.6B | $1.5B |
| 总资产 | $3.4B | $6.0B |
| 负债/权益比越低杠杆越低 | 0.28× | — |
8季度趋势，按日历期对齐
现金及短期投资IDXXNET
| Q4 25 | $180.1M | $943.5M | ||
| Q3 25 | $208.2M | $1.1B | ||
| Q2 25 | $164.6M | $1.5B | ||
| Q1 25 | $164.0M | $204.5M | ||
| Q4 24 | $288.3M | $147.7M | ||
| Q3 24 | $308.6M | $182.9M | ||
| Q2 24 | $401.6M | $157.0M | ||
| Q1 24 | $397.4M | $254.4M |
总债务IDXXNET
| Q4 25 | $450.0M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $617.8M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益IDXXNET
| Q4 25 | $1.6B | $1.5B | ||
| Q3 25 | $1.6B | $1.3B | ||
| Q2 25 | $1.5B | $1.2B | ||
| Q1 25 | $1.4B | $1.4B | ||
| Q4 24 | $1.6B | $1.0B | ||
| Q3 24 | $1.6B | $973.1M | ||
| Q2 24 | $1.6B | $881.5M | ||
| Q1 24 | $1.6B | $797.2M |
总资产IDXXNET
| Q4 25 | $3.4B | $6.0B | ||
| Q3 25 | $3.4B | $5.8B | ||
| Q2 25 | $3.3B | $5.6B | ||
| Q1 25 | $3.2B | $3.7B | ||
| Q4 24 | $3.3B | $3.3B | ||
| Q3 24 | $3.4B | $3.1B | ||
| Q2 24 | $3.4B | $2.9B | ||
| Q1 24 | $3.4B | $2.8B |
负债/权益比IDXXNET
| Q4 25 | 0.28× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.39× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $355.8M | $190.4M |
| 自由现金流经营现金流 - 资本支出 | $326.3M | $105.2M |
| 自由现金流率自由现金流/营收 | 29.9% | 17.1% |
| 资本支出强度资本支出/营收 | 2.7% | 13.9% |
| 现金转化率经营现金流/净利润 | 1.43× | — |
| 过去12个月自由现金流最近4个季度 | $1.1B | $287.5M |
8季度趋势，按日历期对齐
经营现金流IDXXNET
| Q4 25 | $355.8M | $190.4M | ||
| Q3 25 | $402.3M | $167.1M | ||
| Q2 25 | $185.7M | $99.8M | ||
| Q1 25 | $238.0M | $145.8M | ||
| Q4 24 | $262.0M | $127.3M | ||
| Q3 24 | $220.1M | $104.7M | ||
| Q2 24 | $248.3M | $74.8M | ||
| Q1 24 | $198.6M | $73.6M |
自由现金流IDXXNET
| Q4 25 | $326.3M | $105.2M | ||
| Q3 25 | $371.2M | $82.5M | ||
| Q2 25 | $151.6M | $39.9M | ||
| Q1 25 | $207.9M | $59.9M | ||
| Q4 24 | $232.8M | $54.2M | ||
| Q3 24 | $192.0M | $54.5M | ||
| Q2 24 | $215.0M | $45.2M | ||
| Q1 24 | $168.3M | $41.5M |
自由现金流率IDXXNET
| Q4 25 | 29.9% | 17.1% | ||
| Q3 25 | 33.6% | 14.7% | ||
| Q2 25 | 13.7% | 7.8% | ||
| Q1 25 | 20.8% | 12.5% | ||
| Q4 24 | 24.4% | 11.8% | ||
| Q3 24 | 19.7% | 12.7% | ||
| Q2 24 | 21.4% | 11.3% | ||
| Q1 24 | 17.5% | 11.0% |
资本支出强度IDXXNET
| Q4 25 | 2.7% | 13.9% | ||
| Q3 25 | 2.8% | 15.1% | ||
| Q2 25 | 3.1% | 11.7% | ||
| Q1 25 | 3.0% | 17.9% | ||
| Q4 24 | 3.1% | 15.9% | ||
| Q3 24 | 2.9% | 11.7% | ||
| Q2 24 | 3.3% | 7.4% | ||
| Q1 24 | 3.1% | 8.5% |
现金转化率IDXXNET
| Q4 25 | 1.43× | — | ||
| Q3 25 | 1.47× | — | ||
| Q2 25 | 0.63× | — | ||
| Q1 25 | 0.98× | — | ||
| Q4 24 | 1.21× | — | ||
| Q3 24 | 0.95× | — | ||
| Q2 24 | 1.22× | — | ||
| Q1 24 | 0.84× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
IDXX
| Vet Lab Consumables | $389.0M | 36% |
| Reference Laboratory Diagnostic And Consulting Services | $349.2M | 32% |
| Rapid Assay Products | $76.0M | 7% |
| Recurring Revenue | $70.6M | 6% |
| CAG Diagnostic Capital Instruments | $58.1M | 5% |
| Water Segment | $50.5M | 5% |
| Livestock And Poultry Diagnostics Segment | $37.5M | 3% |
| CAG Diagnostics Service And Accessories | $35.3M | 3% |
| Systems And Hardware | $20.1M | 2% |
| Rebate And Up Front Considerations Arrangements | $2.4M | 0% |
| Extended Warranties And Post Contract Support Revenue | $1.0M | 0% |
NET
| Sales Channel Directly To Consumer | $438.5M | 71% |
| Sales Channel Through Intermediary | $176.0M | 29% |
